Nabeel Akhter
Vascular & Interventional Radiology · Baltimore, MDNPI 1487847075
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Boston Scientific at 42.5% of the total. Reporting peaked in 2022 at $3,261 and has fallen 68.2% since, to $1,038 in 2025.
Across 77 payments — averaging $186.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Penumbra, Inc.$4K
- Canon Medical Systems USA, Inc.$3K
- Biocompatibles, Inc.$981
- Angiodynamics, Inc.$398
- Intera Oncology, Inc$228
- plus $168 from 5 others
What the payments were for
- Consulting fees$2,50017%
- Travel & lodging$6,57646%
- Food & beverage$5,26737%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 46 | $6,088 |
| Penumbra, Inc. | 13 | $3,940 |
| Canon Medical Systems USA, Inc. | 2 | $2,540 |
| Biocompatibles, Inc. | 4 | $981 |
| Angiodynamics, Inc. | 4 | $398 |
| Intera Oncology, Inc | 1 | $228 |
| Bard Peripheral Vascular, Inc. | 3 | $60 |
| BD | 1 | $43 |
| Sirtex Medical Inc | 1 | $30 |
| Inari Medical, Inc. | 1 | $20 |
| Surmodics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSphere Y90 Glass Microspheres 10 GBq$3,831
- Indigo System$3,710
- VASCULAR$2,500
- THERASPHERE-BIO$949
- OBSIDIO$761
- GENERAL - THERAPIES$607
- INTERA$228
- AlphaVac$169
- RUBY Coil$140
- GENERAL GUIDEWIRES$115
- Nanoknife$113
How this compares
$14,342 in reported general payments places this provider in the 80th percentile of 75 vascular & interventional radiology providers in Maryland.
See all vascular & interventional radiology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 27 | $381 |
| Ondansetron Hcl | 25 | $99 |
| Hydromorphone Hcl | 15 | $46 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Baltimore
- Nariman NezamiBaltimore$412K
- Philippe GailloudBaltimore$159K
- Christos GeorgiadesBaltimore$37K
- Zachariah Blegen-DipietroBaltimore$23K
- Hyun KimBaltimore$18K
- Grafe LyonsBaltimore$12K
- Robert LiddellBaltimore$9K
- Vahid EtezadiBaltimore$8K
- Nikhil BhagatBaltimore$6K
- Brian HollyBaltimore$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.